Q-omics provides the consensus-scored MIR3162 profile across patient tissues and cancer cell-line models. MIR3162 expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in LUAD. Among the 18 cancer types available for tumor–normal comparison, MIR3162 is differentially expressed in 2, with the highest sampling consensus in THCA. Additionally, MIR3162 RNA expression shows 6,571 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight LUAD, THCA, and ESCA as cancer lineages where MIR3162 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR3162 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR3162 survival associations across molecular data types. MIR3162 RNA expression shows survival associations in the most cancer types (10). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR3162 RNA expression–survival associations across cancer types. High MIR3162 expression shows unfavorable associations in LUAD, UCS, KIRP, UVM, CESC and LIHC. The LUAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LUAD as the clearest survival context for MIR3162 RNA expression.
This table summarizes MIR3162 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for MIR3162. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR3162 shows lower tumor expression in THCA and higher tumor expression in KIRC. The THCA box plot shows higher MIR3162 RNA expression in normal versus tumor tissue (log2 FC = −0.234, t-test p = .018).
This table shows molecular features associated with MIR3162 in patient tissues and cancer cell lines. In patient samples, MIR3162 shows the broadest associations at the RNA and protein expression levels, with ESCA recurring as the lineage with the largest associated feature set.
